viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Levofolinate calcium
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Calc Levof
Itaalia
Calcium levofolinat
Austria
Elvorine
Belgia, Luksemburg, Maroko, Prantsusmaa
Folaxin
Hispaania
Folinate EG
Belgia
Isovorin
Austria, Hispaania, Island, Kreeka, Rootsi, Soome, Suurbritannia, Taani
Levofolatino de calcio
Portugal
Levofolene
Itaalia
Viited : Levofolinate calcium
tüüp
avaldamine
3
ajaleht
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155
ajaleht
Trissel LA, Martinez JF, Xu QA.
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520
Labor
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1914
Labor
Pemetrexed (Alimta®) - Summary of Product Characteristics
Eli Lilly 2016
2130
ajaleht
Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Bull Cancer 1999 ; 86, 11: 946-954.
2181
ajaleht
Milano G, Renée N.
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Bull Cancer 1995 ; 82: 189-195.
2295
Labor
Fosaprepitant (Emend®) - Summary of Product Characteristics
Merck Sharp Dohme 2013
2361
ajaleht
Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531
ajaleht
Sanogo S, Silimbani P, Gaggeri R, Masini C.
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369
Labor
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
MEDAC France 2011
3523
Labor
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018
3546
Labor
Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3619
Labor
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
Wockhardt 2016
3621
Labor
Phosphate dipotassique - Résumé des caractéristiques du produit
Renaudin 2008
3662
Labor
Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
3753
Labor
Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
Cubist Pharmaceuticals 2014
3838
Labor
Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3933
Labor
Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
Teva Laboratoire 2015
4154
Labor
Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4720
Labor
Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
Paratek Pharmaceuticals 2021
Mentions Légales